Mead Johnson Nutrition Reports Second Quarter and First Half 2016 Results; Reaffirms 2016 EPS Guidance; Announces an Expansion of Cost Productivity Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St rebounds with broad gains as oil slides sharply
- Brent hits lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
BMO Capital Remains Bullish on Mead Johnson (MJN) Following 2Q Report
July 29, 2016 9:22 AM EDTBMO Capital reiterated an Outperform rating with a $97.00 price target on Mead Johnson Nutrition (NYSE: MJN) following the company's 2Q earnings report. MJN reported EPS of $0.88, above $0.81 estimates. The company reiterated EPS guidance of $3.48-3.60.
Analyst Amit Sharma commented, "MJN reported 2Q16 adjusted EPS of $0.88,... More
Societe Generale Downgrades Mead Johnson Nutrition (MJN) to Hold
July 29, 2016 6:52 AM EDTSociete Generale downgraded Mead Johnson Nutrition (NYSE: MJN) from Buy to Hold with a price target of $95.00 (from $100.00).
For an analyst ratings summary and ratings history on Mead Johnson Nutrition click here. For more ratings news on Mead Johnson Nutrition click here.
Shares of Mead Johnson Nutrition closed at $89.89 yesterday.
... MoreMead Johnson (MJN) Tops Q2 EPS by 10c, Sales Miss; Reaffirms EPS Outlook
July 28, 2016 7:43 AM EDTMead Johnson (NYSE: MJN) reported Q2 EPS of $0.88, $0.10 better than the analyst estimate of $0.78. Revenue for the quarter came in at $941.5 million versus the consensus estimate of $963.66 million.
"As we move through this year, I am pleased that we continue to deliver against our... More
